Immune but infectious: Can someone vaccinated against COVID-19 still spread the virus? - Global News | Canada News Media
Connect with us

Business

Immune but infectious: Can someone vaccinated against COVID-19 still spread the virus? – Global News

Published

 on


As the cross-Canada roll-out of COVID-19 vaccines continues this week, it’s still unclear whether the injections can actually prevent the spread of the virus.

While both the Pfizer-BioNTech and Moderna products have been shown to be about 95 per cent effective at preventing symptomatic COVID-19 illness, there is not much evidence they can protect those around the person who got the shots.

“Yes, you are still contagious,” Dr. Hana El Sahly told Global News.

El Sahly was one of the lead investigators for Moderna’s late-stage COVID-19 vaccine trial. She says the novel coronavirus can live in the nasal passage for weeks, meaning a vaccinated person could still infect others, even if they don’t get sick. But there was one promising result in the study.

“We did find, in the short term, that those who got the vaccine were less likely to carry [the virus], but the numbers were really small,” El Sahly said.

Story continues below advertisement

Read more:
Advocates call for targeted approach to address COVID-19 vaccine hesitancy in Canada

Both the Moderna and the Pfizer vaccines require people to get two doses, about a month apart, to be effective.

Twenty-nine days after their first dose of Moderna, 14 study participants were found to be carrying the virus — versus the 38 people who received a placebo.

“It’s a signal in the right direction, but nonetheless it cannot be interpreted that the vaccine prevents transmission.”






2:02
Alberta’s COVID-19 vaccine rollout rate and the plan to ramp it up


Alberta’s COVID-19 vaccine rollout rate and the plan to ramp it up

Dr. Jason Kindrachuk, Canada Research Chair in Emerging Viruses, explains the mRNA-based vaccine teaches our immune system to fight the virus, but it doesn’t block it from entering our body.

“People may be able to still get infected even though they’re vaccinated, but it’s a sub-clinical infection — so they don’t feel sick, they don’t have any symptoms, but they may still be able to transmit,” said Kindrachuk.

Story continues below advertisement

Read more:
How long will the COVID-19 vaccine protect you? Here’s what we know so far

Ongoing research will determine if any COVID vaccine can actually prevent transmission. That will require “collecting a lot of nose swabs on a lot of people,” according to El Sahly.

While asymptomatic carriers are less likely to spread the virus than someone who is coughing and sneezing, masks, distancing and hand-washing will still be critical in 2021 until most Canadians can be vaccinated.

“As we build up that immunity in the public, there is lower and lower… ability for the virus to be able to leap from one person to another,” Kindrachuk said.

Some experts suggest at least 70 to 75 per cent of a population will have to be immunized to control the spread of the virus.

That said, the percentage of the Canadian population that needs to be vaccinated in order to reach confidently herd immunity is unknown, according to Canada’s chief public health officer Dr. Theresa Tam.

“We have an assumption that you will probably need 60 to 70 per cent of people to be vaccinated. But we don’t know that for sure … that’s modelling,” Tam told a media conference on December 4.






2:18
How Canada’s COVID-19 vaccine rollout plan is unfolding


How Canada’s COVID-19 vaccine rollout plan is unfolding – Dec 14, 2020

Still, the vaccines are providing some comfort for stressed health-care workers. Pediatric emergency physician Samina Ali received her first dose of the Pfizer vaccine on Jan. 2.

Story continues below advertisement

“It was just so much overwhelming relief… it felt like… as a community, as a world, this was a sign that we were on the way to healing,” Dr. Ali said.

Read more:
Alberta’s COVID-19 vaccine rollout rate and the plan to ramp it up

How Pfizer’s and Moderna’s mRNA-based COVID-19 vaccines work

A vaccine is generally made up of a weakened or a dead virus, which, once injected, prompts the body to fight off the invader and build immunity.

Both Pfizer and Moderna’s candidates have been manufactured using mRNA-based technology, a relatively new way to make vaccines.

Instead of injecting a deactivated form of the virus, the mRNA vaccine uses a component of the virus DNA called messenger RNA that basically contains the genetic instructions for the human body to make the specific spike protein of the coronavirus.

By doing this, the immune system learns to recognize and respond to that specific protein, meaning it can more quickly mount a response if the virus enters the body. The mRNA, however, does not modify a person’s DNA or genetic makeup.

“When your body actually sees the real virus, then you have the weapons already in place — the antibodies and the cells that know this virus that can recognize it — and can kill it faster,” Dr. Donald Vinh, an infectious disease specialist and a medical microbiologist at the McGill University Health Centertold Global News.

Story continues below advertisement

Read more:
AHS ‘actively recruiting’ more staff to help with COVID-19 immunization

According to the data from the clinical trials, Pfizer’s vaccine, which is 95 per cent effective, can offer partial protection as early as 12 days after the first dose.

That protection can last for at least two months, according to Vinh. A second dose is then required to achieve the vaccine’s full potential.

The Moderna vaccine, which also requires a second shot, has shown to be 94 per cent effective.






3:07
Health Canada approves Moderna’s COVID-19 vaccine


Health Canada approves Moderna’s COVID-19 vaccine – Dec 23, 2020

— With files from Saba Aziz, Global News

© 2021 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version